| Preface to the Eleventh Edition |
|
xv | |
| Preface to the First Edition |
|
xvi | |
|
|
|
1 | (18) |
|
Functional anatomy: sectors and segments |
|
|
2 | (1) |
|
Anatomy of the biliary tract |
|
|
3 | (1) |
|
Development of the liver and bile ducts |
|
|
4 | (1) |
|
Anatomical abnormalities of the liver |
|
|
4 | (1) |
|
|
|
5 | (1) |
|
|
|
5 | (1) |
|
|
|
6 | (3) |
|
Electron microscopy and hepato-cellular function |
|
|
9 | (2) |
|
|
|
11 | (2) |
|
Hepatocyte death and regeneration |
|
|
13 | (1) |
|
|
|
14 | (1) |
|
Altered hepatic microcirculation and disease |
|
|
14 | (1) |
|
|
|
14 | (1) |
|
|
|
14 | (2) |
|
Sinusoidal membrane traffic |
|
|
16 | (1) |
|
Bile duct epithelial cells |
|
|
16 | (3) |
|
Assessment of Liver Function |
|
|
19 | (18) |
|
Selection of biochemical tests |
|
|
19 | (1) |
|
|
|
20 | (1) |
|
|
|
20 | (1) |
|
|
|
20 | (1) |
|
|
|
21 | (1) |
|
|
|
21 | (2) |
|
|
|
21 | (1) |
|
Gamma glutamyl transpeptidase |
|
|
22 | (1) |
|
|
|
22 | (1) |
|
|
|
23 | (1) |
|
Quantitative assessment of hepatic function |
|
|
23 | (3) |
|
Galactose elimination capacity |
|
|
23 | (1) |
|
|
|
23 | (1) |
|
Salivary caffeine clearance |
|
|
24 | (1) |
|
Lignocaine metabolite formation |
|
|
25 | (1) |
|
Arterial blood ketone body ratio |
|
|
25 | (1) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
Asialoglycoprotein receptor |
|
|
25 | (1) |
|
|
|
25 | (1) |
|
Lipid and lipoprotein metabolism |
|
|
26 | (2) |
|
|
|
26 | (1) |
|
|
|
26 | (1) |
|
|
|
27 | (1) |
|
|
|
28 | (3) |
|
|
|
29 | (1) |
|
|
|
30 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
32 | (2) |
|
Electrophoretic pattern of serum proteins |
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Effects of ageing on the liver |
|
|
34 | (3) |
|
|
|
37 | (10) |
|
Selection and preparation of the patient |
|
|
37 | (1) |
|
|
|
37 | (3) |
|
|
|
40 | (1) |
|
Liver biopsy in paediatrics |
|
|
40 | (1) |
|
|
|
40 | (3) |
|
Pleurisy and peri-hepatitis |
|
|
40 | (1) |
|
|
|
40 | (1) |
|
|
|
41 | (1) |
|
|
|
41 | (1) |
|
|
|
42 | (1) |
|
|
|
42 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
Preparation of the specimen |
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
44 | (1) |
|
|
|
44 | (3) |
|
The Haematology of Liver Disease |
|
|
47 | (20) |
|
|
|
47 | (2) |
|
The liver and blood coagulation |
|
|
49 | (4) |
|
|
|
53 | (1) |
|
The liver in haemolytic anaemias |
|
|
54 | (2) |
|
|
|
54 | (1) |
|
|
|
55 | (1) |
|
Paroxysmal nocturnal haemoglobinuria |
|
|
56 | (1) |
|
Acquired haemolytic anaemia |
|
|
56 | (1) |
|
Haemolytic disease of the newborn |
|
|
56 | (1) |
|
Incompatible blood transfusion |
|
|
56 | (1) |
|
The liver in myelo- and lymphoproliferative disease |
|
|
56 | (1) |
|
|
|
57 | (1) |
|
|
|
57 | (1) |
|
|
|
57 | (1) |
|
|
|
57 | (1) |
|
Bone marrow transplantation |
|
|
57 | (1) |
|
|
|
58 | (4) |
|
|
|
59 | (1) |
|
|
|
60 | (1) |
|
|
|
60 | (1) |
|
|
|
61 | (1) |
|
Angio-immunoblastic lymphadenopathy |
|
|
61 | (1) |
|
Extra-medullary haemopoiesis |
|
|
61 | (1) |
|
|
|
61 | (1) |
|
Langerhans' cell histiocytosis (histiocytosis X) |
|
|
61 | (1) |
|
|
|
62 | (5) |
|
Primary and secondary xanthomatosis |
|
|
62 | (1) |
|
Cholesteryl ester storage disease |
|
|
62 | (1) |
|
|
|
62 | (1) |
|
|
|
63 | (1) |
|
Sea-blue histiocyte syndrome |
|
|
64 | (3) |
|
Ultrasound, Computed Tomography and Magnetic Resonance Imaging |
|
|
67 | (14) |
|
|
|
67 | (1) |
|
Positron emission tomography (PET) |
|
|
67 | (1) |
|
|
|
67 | (3) |
|
|
|
69 | (1) |
|
|
|
70 | (1) |
|
|
|
70 | (4) |
|
Magnetic resonance imaging |
|
|
74 | (3) |
|
|
|
76 | (1) |
|
|
|
77 | (4) |
|
|
|
81 | (12) |
|
General failure of health |
|
|
81 | (1) |
|
|
|
81 | (1) |
|
Vasodilatation and hyperdynamic circulation |
|
|
81 | (5) |
|
Hepato-pulmonary syndrome |
|
|
82 | (2) |
|
|
|
84 | (2) |
|
|
|
86 | (1) |
|
|
|
87 | (1) |
|
Changes in nitrogen metabolism |
|
|
87 | (1) |
|
|
|
87 | (2) |
|
|
|
87 | (1) |
|
Palmar erythema (liver palms) |
|
|
88 | (1) |
|
|
|
89 | (1) |
|
Mechanism of skin changes |
|
|
89 | (1) |
|
|
|
89 | (3) |
|
|
|
90 | (1) |
|
Hypothalmaic-pituitary function |
|
|
91 | (1) |
|
|
|
91 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
93 | (18) |
|
|
|
93 | (4) |
|
|
|
95 | (1) |
|
Neuropathological changes |
|
|
96 | (1) |
|
Clinical variants in cirrhotics |
|
|
97 | (2) |
|
|
|
98 | (1) |
|
|
|
99 | (1) |
|
|
|
99 | (5) |
|
Portal-systemic encephalopathy |
|
|
99 | (1) |
|
|
|
100 | (1) |
|
|
|
100 | (3) |
|
|
|
103 | (1) |
|
Treatment of hepatic encephalopathy |
|
|
104 | (7) |
|
|
|
104 | (1) |
|
|
|
105 | (1) |
|
|
|
105 | (1) |
|
Sodium benzoate and L-ornithine-L-aspartate |
|
|
106 | (1) |
|
Levodopa and bromocriptine |
|
|
106 | (1) |
|
|
|
106 | (1) |
|
Branched-chain amino acids |
|
|
106 | (1) |
|
Other precipitating factors |
|
|
106 | (1) |
|
|
|
106 | (1) |
|
Temporary hepatic support |
|
|
107 | (1) |
|
|
|
107 | (4) |
|
|
|
111 | (16) |
|
|
|
111 | (1) |
|
|
|
111 | (2) |
|
|
|
113 | (1) |
|
|
|
113 | (2) |
|
|
|
115 | (3) |
|
|
|
118 | (1) |
|
|
|
119 | (5) |
|
|
|
124 | (3) |
|
|
|
127 | (20) |
|
Mechanism of ascites formation |
|
|
127 | (3) |
|
Underfill and peripheral vasodilation hypotheses |
|
|
127 | (2) |
|
|
|
129 | (1) |
|
|
|
129 | (1) |
|
|
|
130 | (1) |
|
|
|
130 | (1) |
|
|
|
130 | (2) |
|
Spontaneous bacterial peritonitis |
|
|
132 | (2) |
|
Treatment of cirrhotic ascites |
|
|
134 | (6) |
|
|
|
138 | (1) |
|
|
|
139 | (1) |
|
|
|
140 | (3) |
|
|
|
143 | (4) |
|
The Portal Venous System and Portal Hypertension |
|
|
147 | (40) |
|
|
|
147 | (1) |
|
Intra-hepatic obstruction (cirrhosis) |
|
|
147 | (1) |
|
Extra-hepatic obstruction |
|
|
148 | (1) |
|
|
|
148 | (1) |
|
Pathology of portal hypertension |
|
|
148 | (1) |
|
|
|
149 | (2) |
|
Portal hypertensive intenstinal vasculopathy |
|
|
151 | (1) |
|
Haemodynamics of portal hypertension |
|
|
151 | (1) |
|
Clinical features of portal hypertension |
|
|
152 | (5) |
|
History and general examination |
|
|
152 | (1) |
|
|
|
153 | (1) |
|
|
|
154 | (1) |
|
|
|
154 | (1) |
|
|
|
154 | (1) |
|
|
|
154 | (1) |
|
X-ray of the abdomen and chest |
|
|
154 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (2) |
|
Imaging the portal venous system |
|
|
157 | (6) |
|
|
|
157 | (1) |
|
|
|
157 | (1) |
|
|
|
158 | (1) |
|
Magnetic resonance angiography |
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
159 | (1) |
|
Digital subtraction angiography |
|
|
159 | (1) |
|
|
|
159 | (1) |
|
Carbon dioxide wedged venography |
|
|
160 | (1) |
|
Portal pressure measurement |
|
|
160 | (1) |
|
|
|
160 | (1) |
|
Estimation of hepatic blood flow |
|
|
161 | (1) |
|
|
|
162 | (1) |
|
Experimental portal venous occlusion and hypertension |
|
|
163 | (1) |
|
Classification of portal hypertension |
|
|
163 | (1) |
|
Extra-hepatic portal venous obstruction |
|
|
163 | (5) |
|
|
|
163 | (2) |
|
|
|
165 | (1) |
|
|
|
166 | (1) |
|
|
|
167 | (1) |
|
|
|
167 | (1) |
|
Hepatic arterio-portal venous fistulae |
|
|
167 | (1) |
|
Porto-hepatic venous shunts |
|
|
168 | (1) |
|
Intra-heaptic pre-sinusoidal and sinusoidal portal hypertension |
|
|
168 | (1) |
|
|
|
168 | (1) |
|
|
|
168 | (1) |
|
|
|
168 | (1) |
|
Tropical splenomegaly syndrome |
|
|
169 | (1) |
|
Intra-hepatic portal hypertension |
|
|
169 | (1) |
|
|
|
169 | (1) |
|
|
|
170 | (1) |
|
Bleeding oesophageal varices |
|
|
170 | (3) |
|
|
|
170 | (1) |
|
|
|
171 | (1) |
|
|
|
172 | (1) |
|
|
|
172 | (1) |
|
Management of acute variceal bleeding |
|
|
173 | (4) |
|
|
|
174 | (1) |
|
Sengstaken-Blakemore tube |
|
|
174 | (1) |
|
Endoscopic sclerotherapy and banding |
|
|
175 | (1) |
|
|
|
176 | (1) |
|
Prevention of re-bleeding |
|
|
176 | (1) |
|
Portal-systemic shunt procedures |
|
|
177 | (3) |
|
|
|
177 | (1) |
|
|
|
178 | (1) |
|
Selective `distal' spleno-renal |
|
|
178 | (1) |
|
General results of portal-systemic shunts |
|
|
178 | (1) |
|
TIPS (transjugular intrahepatic portosystemic shunt) |
|
|
178 | (1) |
|
Shunt stenosis and occlusion |
|
|
179 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
|
|
180 | (1) |
|
Pharmacological control of the portal circulation |
|
|
180 | (1) |
|
|
|
180 | (7) |
|
The Hepatic Artery and Hepatic Veins: the Liver in Circulatory Failure |
|
|
187 | (18) |
|
|
|
187 | (3) |
|
|
|
188 | (1) |
|
Hepatic arterial lesions following liver transplantation |
|
|
189 | (1) |
|
Aneurysms of the hepatic artery |
|
|
189 | (1) |
|
Hepatic arteriovenous shunts |
|
|
190 | (1) |
|
|
|
190 | (2) |
|
Experimental hepatic venous obstruction |
|
|
191 | (1) |
|
Budd-Chiari (hepatic venous obstruction) syndrome |
|
|
192 | (7) |
|
|
|
193 | (1) |
|
|
|
193 | (2) |
|
|
|
195 | (1) |
|
|
|
196 | (1) |
|
|
|
197 | (1) |
|
|
|
198 | (1) |
|
Spread of disease by the hepatic veins |
|
|
198 | (1) |
|
|
|
199 | (6) |
|
Hepatic changes in acute heart failure and shock |
|
|
199 | (1) |
|
|
|
200 | (1) |
|
|
|
200 | (1) |
|
Jaundice after cardiac surgery |
|
|
201 | (1) |
|
The liver in congestive heart failure |
|
|
201 | (2) |
|
The liver in constrictive pericardities |
|
|
203 | (2) |
|
|
|
205 | (14) |
|
|
|
205 | (3) |
|
Hepatic transport and conjugation of bilirubin |
|
|
205 | (2) |
|
Distribution of jaundice in the tissues |
|
|
207 | (1) |
|
Factors determining the depth of jaundice |
|
|
207 | (1) |
|
Classification of jaundice |
|
|
208 | (1) |
|
|
|
209 | (4) |
|
|
|
209 | (2) |
|
|
|
211 | (1) |
|
|
|
212 | (1) |
|
Familial non-haemolytic hyperbilirubinaemias |
|
|
213 | (6) |
|
Primary hyperbilirubinaemia |
|
|
213 | (1) |
|
|
|
213 | (2) |
|
|
|
215 | (1) |
|
|
|
216 | (1) |
|
|
|
217 | (1) |
|
The group of familial non-haemolytic hyperbilirubinaemias |
|
|
217 | (2) |
|
|
|
219 | (22) |
|
Anatomy of the biliary system |
|
|
219 | (1) |
|
|
|
220 | (3) |
|
|
|
221 | (2) |
|
|
|
223 | (18) |
|
|
|
223 | (1) |
|
|
|
223 | (1) |
|
|
|
224 | (1) |
|
|
|
224 | (2) |
|
|
|
226 | (5) |
|
|
|
231 | (1) |
|
|
|
232 | (9) |
|
Primary Biliary Cirrhosis |
|
|
241 | (14) |
|
|
|
241 | (2) |
|
Epidemiology and genetics |
|
|
243 | (1) |
|
|
|
243 | (3) |
|
|
|
246 | (1) |
|
|
|
247 | (1) |
|
|
|
248 | (2) |
|
|
|
250 | (3) |
|
|
|
253 | (2) |
|
|
|
255 | (12) |
|
Primary sclerosing cholangitis (PSC) |
|
|
255 | (6) |
|
Infective sclerosing cholangitis |
|
|
261 | (2) |
|
|
|
261 | (1) |
|
Immunodeficiency-related opportunistic cholangitis |
|
|
261 | (2) |
|
Graft-versus-host disease |
|
|
263 | (1) |
|
|
|
263 | (1) |
|
|
|
263 | (1) |
|
|
|
263 | (4) |
|
Viral Hepatitis: General Features, Hepatitis A, Hepatitis E and Other Viruses |
|
|
267 | (18) |
|
|
|
267 | (1) |
|
|
|
268 | (3) |
|
|
|
271 | (1) |
|
|
|
271 | (1) |
|
|
|
272 | (1) |
|
|
|
272 | (1) |
|
|
|
272 | (1) |
|
|
|
273 | (3) |
|
|
|
274 | (1) |
|
|
|
275 | (1) |
|
|
|
275 | (1) |
|
|
|
275 | (1) |
|
|
|
276 | (2) |
|
|
|
277 | (1) |
|
|
|
277 | (1) |
|
|
|
277 | (1) |
|
|
|
277 | (1) |
|
|
|
278 | (1) |
|
|
|
278 | (1) |
|
|
|
279 | (1) |
|
|
|
279 | (1) |
|
|
|
279 | (1) |
|
|
|
279 | (1) |
|
Infectious mononucleosis (Epstein-Barr virus) |
|
|
279 | (2) |
|
|
|
279 | (1) |
|
|
|
280 | (1) |
|
|
|
280 | (1) |
|
Distinction from viral hepatitis |
|
|
280 | (1) |
|
|
|
281 | (1) |
|
|
|
281 | (1) |
|
|
|
281 | (1) |
|
|
|
281 | (1) |
|
Hepatitis due to exotic viruses |
|
|
282 | (3) |
|
|
|
283 | (2) |
|
Hepatitis B Virus and Hepatitis Delta Virus |
|
|
285 | (20) |
|
|
|
285 | (9) |
|
|
|
287 | (3) |
|
|
|
290 | (1) |
|
|
|
290 | (2) |
|
|
|
292 | (2) |
|
|
|
294 | (6) |
|
Clinical relapse and reactivation |
|
|
294 | (1) |
|
|
|
295 | (1) |
|
|
|
295 | (1) |
|
|
|
295 | (1) |
|
|
|
296 | (2) |
|
|
|
298 | (1) |
|
Screening for hepato-cellular carcinoma |
|
|
298 | (2) |
|
Hepatitis delta virus (HDV) |
|
|
300 | (5) |
|
|
|
300 | (1) |
|
|
|
301 | (1) |
|
|
|
301 | (1) |
|
|
|
302 | (1) |
|
|
|
302 | (1) |
|
|
|
302 | (3) |
|
|
|
305 | (16) |
|
|
|
305 | (1) |
|
|
|
306 | (1) |
|
|
|
307 | (1) |
|
|
|
307 | (1) |
|
|
|
308 | (1) |
|
|
|
308 | (1) |
|
|
|
309 | (1) |
|
Hepatitis C and serum autoantibodies |
|
|
310 | (1) |
|
|
|
310 | (1) |
|
|
|
311 | (1) |
|
|
|
311 | (1) |
|
|
|
312 | (1) |
|
|
|
312 | (4) |
|
|
|
316 | (5) |
|
Chronic Hepatitis: General Features, and Autoimmune Chronic Disease |
|
|
321 | (14) |
|
|
|
321 | (1) |
|
|
|
322 | (1) |
|
|
|
322 | (2) |
|
|
|
324 | (1) |
|
Autoimmune chronic hepatitis |
|
|
325 | (1) |
|
Type 1 (formerly called lupoid) |
|
|
326 | (1) |
|
|
|
326 | (1) |
|
Primary biliary cirrhosis and immune cholangitis |
|
|
326 | (1) |
|
Chronic autoimmune hepatitis (type 1) |
|
|
326 | (9) |
|
|
|
326 | (2) |
|
|
|
328 | (1) |
|
|
|
328 | (2) |
|
|
|
330 | (1) |
|
|
|
331 | (1) |
|
|
|
332 | (1) |
|
Syncytial giant-cell hepatitis |
|
|
332 | (3) |
|
|
|
335 | (30) |
|
Hepato-cellular zone 3 necrosis |
|
|
340 | (4) |
|
|
|
342 | (1) |
|
|
|
343 | (1) |
|
Paracetamol (acetaminophen) |
|
|
343 | (1) |
|
|
|
344 | (1) |
|
|
|
344 | (1) |
|
|
|
344 | (1) |
|
|
|
344 | (1) |
|
Hepato-cellular zone 1 necrosis |
|
|
344 | (1) |
|
|
|
345 | (1) |
|
|
|
345 | (1) |
|
Mitochondrial cytopathies |
|
|
345 | (1) |
|
|
|
345 | (1) |
|
|
|
345 | (1) |
|
|
|
345 | (1) |
|
Antiviral nucleoside analogues |
|
|
345 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
346 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (1) |
|
|
|
347 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (1) |
|
|
|
348 | (1) |
|
|
|
349 | (1) |
|
Veno-occlusive disease (VOD) |
|
|
349 | (1) |
|
|
|
349 | (5) |
|
|
|
350 | (1) |
|
|
|
351 | (1) |
|
|
|
351 | (1) |
|
|
|
352 | (1) |
|
|
|
352 | (1) |
|
|
|
352 | (1) |
|
|
|
353 | (1) |
|
Sustained-release nicotinic acid (niacin) |
|
|
353 | (1) |
|
Sulphonamides and derivatives |
|
|
353 | (1) |
|
Non-steroidal anti-inflammatory drugs |
|
|
353 | (1) |
|
|
|
353 | (1) |
|
|
|
353 | (1) |
|
|
|
354 | (1) |
|
|
|
354 | (1) |
|
|
|
354 | (1) |
|
|
|
354 | (1) |
|
|
|
355 | (1) |
|
|
|
355 | (1) |
|
|
|
355 | (1) |
|
|
|
355 | (1) |
|
Hepato-canalicular cholestasis |
|
|
355 | (2) |
|
|
|
356 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
Cimetidine and ranitidine |
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
|
|
357 | (1) |
|
Hepatic nodules and tumours |
|
|
358 | (1) |
|
Hepato-cellular carcinoma |
|
|
358 | (1) |
|
|
|
359 | (6) |
|
|
|
365 | (16) |
|
Classification of cirrhosis |
|
|
368 | (3) |
|
|
|
371 | (3) |
|
|
|
374 | (1) |
|
|
|
375 | (1) |
|
|
|
376 | (1) |
|
|
|
377 | (4) |
|
|
|
381 | (18) |
|
Risk factors for alcoholic liver diseases |
|
|
381 | (1) |
|
|
|
382 | (2) |
|
Mechanisms of liver injury |
|
|
384 | (2) |
|
|
|
386 | (4) |
|
|
|
386 | (1) |
|
|
|
387 | (1) |
|
|
|
387 | (2) |
|
|
|
389 | (1) |
|
|
|
389 | (1) |
|
|
|
390 | (3) |
|
|
|
390 | (1) |
|
Acute alcoholic heaptitis |
|
|
390 | (1) |
|
|
|
391 | (1) |
|
|
|
391 | (1) |
|
Relationship to hepatitis B and C |
|
|
391 | (2) |
|
|
|
393 | (1) |
|
|
|
393 | (1) |
|
|
|
393 | (1) |
|
|
|
394 | (5) |
|
Acute alcoholic heaptitis |
|
|
394 | (1) |
|
|
|
395 | (1) |
|
|
|
395 | (4) |
|
|
|
399 | (14) |
|
|
|
399 | (2) |
|
Iron overload and liver damage |
|
|
401 | (1) |
|
|
|
401 | (6) |
|
Other iron storage diseases |
|
|
407 | (6) |
|
Non-HFE-related inherited iron overload |
|
|
407 | (1) |
|
|
|
408 | (1) |
|
|
|
408 | (1) |
|
|
|
408 | (1) |
|
|
|
408 | (1) |
|
Non-alcoholic fatty liver disease |
|
|
408 | (1) |
|
Neonatal haemochromatosis |
|
|
409 | (1) |
|
African iron overload (Bantu siderosis) |
|
|
409 | (1) |
|
|
|
409 | (1) |
|
|
|
409 | (1) |
|
|
|
409 | (1) |
|
|
|
409 | (4) |
|
|
|
413 | (10) |
|
Molecular genetics: pathogenesis |
|
|
413 | (1) |
|
|
|
414 | (1) |
|
|
|
415 | (1) |
|
|
|
416 | (1) |
|
|
|
417 | (1) |
|
|
|
417 | (1) |
|
|
|
417 | (1) |
|
|
|
417 | (1) |
|
|
|
418 | (1) |
|
|
|
418 | (1) |
|
|
|
418 | (1) |
|
|
|
419 | (1) |
|
|
|
420 | (1) |
|
Indian childhood cirrhosis |
|
|
421 | (1) |
|
Hereditary acaeruloplasminaemia |
|
|
421 | (2) |
|
Nutritional and Metabolic Liver Diseases |
|
|
423 | (30) |
|
|
|
423 | (1) |
|
|
|
423 | (4) |
|
|
|
424 | (1) |
|
|
|
424 | (3) |
|
Non-alcoholic fatty liver disease |
|
|
427 | (2) |
|
Non-alcoholic hepatic steatosis |
|
|
428 | (1) |
|
Non-alcoholic steatonecrosis |
|
|
428 | (1) |
|
Effects of jejuno-ileal bypass |
|
|
429 | (1) |
|
|
|
429 | (1) |
|
|
|
429 | (2) |
|
Carbohydrate metabolism in liver disease |
|
|
431 | (1) |
|
|
|
431 | (1) |
|
|
|
431 | (1) |
|
The liver in diabetes mellitus |
|
|
431 | (1) |
|
|
|
431 | (1) |
|
|
|
431 | (1) |
|
|
|
432 | (1) |
|
|
|
432 | (1) |
|
Hepato-biliary disease and diabetes |
|
|
432 | (2) |
|
Glucose intolerance of cirrhosis |
|
|
432 | (1) |
|
Treatment of diabetes in cirrhotic patients |
|
|
433 | (1) |
|
Glycogen storage diseases |
|
|
434 | (4) |
|
Type I (von Gierke's disease) |
|
|
435 | (1) |
|
Type II (Pompe's disease) |
|
|
436 | (1) |
|
Type III (Cori's disease) |
|
|
436 | (1) |
|
Type IV (Andersen's disease) |
|
|
437 | (1) |
|
|
|
437 | (1) |
|
Hepatic glycogen synthetase deficiency (type 0) |
|
|
437 | (1) |
|
Hereditary fructose intolerance |
|
|
438 | (1) |
|
Glutaric aciduria type II |
|
|
438 | (1) |
|
|
|
438 | (1) |
|
|
|
439 | (1) |
|
Familial hypercholesterolaemia |
|
|
439 | (1) |
|
|
|
440 | (3) |
|
|
|
443 | (2) |
|
|
|
445 | (1) |
|
|
|
446 | (1) |
|
|
|
447 | (1) |
|
|
|
447 | (1) |
|
|
|
447 | (1) |
|
Changes with hepato-cellular disease |
|
|
447 | (1) |
|
|
|
448 | (1) |
|
|
|
448 | (1) |
|
|
|
448 | (4) |
|
Acute intermittent porphyria |
|
|
449 | (1) |
|
Hereditary coproporphyria |
|
|
450 | (1) |
|
|
|
450 | (1) |
|
|
|
450 | (1) |
|
Erythropoietic protoporphyria |
|
|
450 | (1) |
|
Congenital erythropoietic porphyria |
|
|
451 | (1) |
|
Hepato-erythropoietic porphyria |
|
|
451 | (1) |
|
Secondary coproporphyrias |
|
|
451 | (1) |
|
Hereditary haemorrhagic telangiectasia |
|
|
452 | (1) |
|
|
|
452 | (1) |
|
The Liver in Infancy and Childhood |
|
|
453 | (18) |
|
Neonatal hyperbilirubinaemia |
|
|
453 | (2) |
|
Unconjugated hyperbilirubinaemia |
|
|
453 | (1) |
|
Haemolytic disease of the newborn |
|
|
454 | (1) |
|
Hepatitis and cholestatic syndromes (conjugated hyperbilirubinaemia) |
|
|
455 | (5) |
|
|
|
457 | (2) |
|
Non-viral causes of hepatitis |
|
|
459 | (1) |
|
|
|
459 | (1) |
|
Neonatal hepatitis syndrome |
|
|
459 | (1) |
|
Infantile cholangiopathies |
|
|
460 | (4) |
|
|
|
460 | (1) |
|
Extra-hepatic biliary atresia |
|
|
460 | (2) |
|
Alagille's syndrome (arterio-hepatic dysplasia) |
|
|
462 | (1) |
|
Prolonged parenteral nutrition |
|
|
462 | (1) |
|
Abnormal bile acid synthesis |
|
|
463 | (1) |
|
Genetic cholestatic syndromes |
|
|
463 | (1) |
|
Symptomatic treatment of cholestatic syndromes |
|
|
464 | (1) |
|
Other causes of cholestatic jaundice |
|
|
464 | (1) |
|
|
|
465 | (1) |
|
|
|
465 | (1) |
|
Cirrhosis in infancy and childhood |
|
|
465 | (2) |
|
Indian childhood cirrhosis |
|
|
466 | (1) |
|
Non-Indian childhood cirrhosis (copper-associated liver disease) |
|
|
466 | (1) |
|
|
|
467 | (1) |
|
|
|
467 | (1) |
|
Idiopathic steato-hepatitis |
|
|
467 | (1) |
|
|
|
467 | (4) |
|
|
|
467 | (1) |
|
|
|
467 | (1) |
|
Malignant mesenchymoma (undifferentiated sarcoma) |
|
|
467 | (1) |
|
|
|
467 | (1) |
|
Hepato-cellular carcinoma |
|
|
467 | (1) |
|
|
|
467 | (1) |
|
Infantile haemangio-endothelioma |
|
|
467 | (1) |
|
Nodular regenerative hyperplasia |
|
|
468 | (1) |
|
|
|
468 | (3) |
|
|
|
471 | (10) |
|
|
|
471 | (1) |
|
Liver disease in pregnancy |
|
|
471 | (1) |
|
|
|
471 | (1) |
|
Liver disases of late pregnancy |
|
|
471 | (5) |
|
Acute fatty liver of pregnancy |
|
|
471 | (3) |
|
|
|
474 | (1) |
|
|
|
474 | (1) |
|
Toxaemia and the HELLP syndrome |
|
|
475 | (1) |
|
|
|
475 | (1) |
|
|
|
475 | (1) |
|
|
|
476 | (1) |
|
|
|
476 | (2) |
|
|
|
476 | (1) |
|
|
|
477 | (1) |
|
Hepato-toxic drugs and the pregnant woman |
|
|
478 | (1) |
|
Effect of pregnancy on pre-existing chronic liver disease |
|
|
478 | (1) |
|
Pregnancy in liver transplant recipients |
|
|
478 | (3) |
|
The Liver in Systemic Disease, Granulomas and Hepatic Trauma |
|
|
481 | (14) |
|
The liver in collagen diseases |
|
|
481 | (1) |
|
Arthropathy associated with liver disease |
|
|
481 | (1) |
|
|
|
481 | (1) |
|
Hepatitis B virus (HBV) associations |
|
|
481 | (1) |
|
Hepatitis C virus (HCV) associations |
|
|
482 | (1) |
|
|
|
482 | (8) |
|
Clinical syndrome of hepatic granulomas |
|
|
483 | (1) |
|
`Granulomatous hepatitis' |
|
|
484 | (1) |
|
|
|
484 | (2) |
|
Granulomatous drug reactions |
|
|
486 | (1) |
|
Granulomas associated with infections |
|
|
487 | (1) |
|
Hepatic granulomas in the patient with AIDS |
|
|
488 | (1) |
|
|
|
489 | (1) |
|
Other conditions with hepatic granulomas |
|
|
489 | (1) |
|
Hepato-biliary associations of inflammatory bowel disease |
|
|
490 | (1) |
|
|
|
490 | (5) |
|
Rupture of the gallbladder |
|
|
492 | (3) |
|
|
|
495 | (32) |
|
|
|
495 | (3) |
|
|
|
498 | (1) |
|
|
|
498 | (3) |
|
Tuberculosis of the liver |
|
|
501 | (1) |
|
|
|
502 | (1) |
|
|
|
502 | (1) |
|
|
|
503 | (1) |
|
|
|
503 | (1) |
|
|
|
503 | (1) |
|
|
|
503 | (1) |
|
Jaundice complicating penicillin treatment |
|
|
504 | (1) |
|
|
|
504 | (3) |
|
|
|
504 | (2) |
|
Other types of leptospirosis |
|
|
506 | (1) |
|
|
|
507 | (1) |
|
|
|
507 | (1) |
|
|
|
507 | (1) |
|
Rocky mountain spotted fever |
|
|
508 | (1) |
|
Schistosomiasis (bilharziasis) |
|
|
508 | (2) |
|
|
|
510 | (1) |
|
Kala-azar (leishmaniasis) |
|
|
511 | (1) |
|
|
|
511 | (6) |
|
Echinococcus multilocularis (alveolar echinococcosis) |
|
|
516 | (1) |
|
|
|
517 | (1) |
|
Strongyloides stercoralis |
|
|
518 | (1) |
|
|
|
518 | (1) |
|
Toxocara canis (visceral larva migrans) |
|
|
518 | (1) |
|
|
|
518 | (2) |
|
|
|
518 | (1) |
|
|
|
519 | (1) |
|
Recurrent pyogenic cholangitis |
|
|
519 | (1) |
|
|
|
520 | (1) |
|
Hepato-biliary disease in HIV infection |
|
|
520 | (5) |
|
|
|
521 | (1) |
|
Hepatitis B, C and D co-infection |
|
|
522 | (1) |
|
|
|
522 | (1) |
|
|
|
523 | (1) |
|
|
|
524 | (1) |
|
|
|
525 | (2) |
|
|
|
525 | (1) |
|
Septicaemia and septic shock |
|
|
525 | (2) |
|
Nodules and Benign Liver Lesions |
|
|
527 | (10) |
|
Small hepato-cellular cancer |
|
|
527 | (1) |
|
Nodules in the absence of underlying liver disease |
|
|
528 | (1) |
|
|
|
528 | (1) |
|
|
|
528 | (2) |
|
Focal nodular hyperplasia |
|
|
530 | (1) |
|
|
|
531 | (1) |
|
Focal nodular hyperplasia and adenoma contrasted |
|
|
532 | (1) |
|
|
|
532 | (2) |
|
|
|
534 | (1) |
|
Cholangioma (bile duct adenoma) |
|
|
534 | (1) |
|
|
|
534 | (1) |
|
Nodular regenerative hyperplasia |
|
|
534 | (3) |
|
Partial nodular transformation |
|
|
535 | (2) |
|
|
|
537 | (26) |
|
|
|
537 | (14) |
|
|
|
537 | (3) |
|
|
|
540 | (1) |
|
|
|
541 | (2) |
|
|
|
543 | (3) |
|
|
|
546 | (1) |
|
|
|
546 | (1) |
|
Prognosis and risk factors |
|
|
547 | (1) |
|
|
|
547 | (1) |
|
|
|
548 | (3) |
|
Fibro-lamellar carcinoma of the liver |
|
|
551 | (1) |
|
|
|
551 | (1) |
|
Intra-hepatic cholangiocarcinoma |
|
|
552 | (1) |
|
Combined hepato-cellular-cholangiocarcinoma |
|
|
553 | (1) |
|
Other primary liver tumours |
|
|
553 | (1) |
|
|
|
553 | (1) |
|
Angiosarcoma (haemangio-endothelioma) |
|
|
553 | (1) |
|
Epitheloid haemangio-endothelioma |
|
|
554 | (1) |
|
Undifferentiated sarcoma of the liver |
|
|
554 | (1) |
|
Benign tumours of the liver |
|
|
554 | (1) |
|
|
|
554 | (1) |
|
Paraneoplastic hepatopathy |
|
|
554 | (1) |
|
|
|
554 | (9) |
|
Imaging of the Biliary Tract: Interventional Radiology and Endoscopy |
|
|
563 | (20) |
|
Plain film of the abdomen |
|
|
563 | (1) |
|
|
|
563 | (1) |
|
|
|
563 | (1) |
|
|
|
563 | (1) |
|
|
|
564 | (1) |
|
Magnetic resonance cholangiopancreatography (MRCP) |
|
|
565 | (1) |
|
Endoscopic ultrasound (EUS) |
|
|
566 | (1) |
|
|
|
567 | (1) |
|
|
|
567 | (1) |
|
Intravenous cholangiography |
|
|
568 | (1) |
|
Endoscopic retrograde cholagiopancreatography |
|
|
568 | (2) |
|
Endoscopic sphincterotomy |
|
|
570 | (3) |
|
Endoscopic biliary endoprostheses |
|
|
573 | (3) |
|
Percutaneous trans-hepatic cholangiography |
|
|
576 | (1) |
|
Percutaneous bile drainage |
|
|
576 | (1) |
|
Percutaneous biliary endoprosthesis |
|
|
577 | (1) |
|
|
|
578 | (1) |
|
Choice between surgical and non-surgical palliation of malignant obstruction |
|
|
578 | (1) |
|
Choice between endoscopic and percutaneous approach |
|
|
578 | (1) |
|
Percutaneous cholecystostomy |
|
|
578 | (1) |
|
Operative and post-operative cholangiography |
|
|
579 | (4) |
|
Cysts and Congenital Biliary Abnormalities |
|
|
583 | (14) |
|
|
|
583 | (1) |
|
Childhood fibropolycystic diseases |
|
|
584 | (1) |
|
|
|
584 | (2) |
|
Congenital hepatic fibrosis |
|
|
586 | (6) |
|
Congenital intra-hepatic biliary dilatation (Caroli's disease) |
|
|
588 | (1) |
|
Congenital hepatic fibrosis and Caroli's disease |
|
|
589 | (1) |
|
|
|
589 | (2) |
|
Microhamartoma (von Meyenberg complexes) |
|
|
591 | (1) |
|
Carcinoma secondary to fibropolycystic disease |
|
|
591 | (1) |
|
Solitary non-parasitic liver cyst |
|
|
591 | (1) |
|
|
|
591 | (1) |
|
Congenital anomalies of the biliary tract |
|
|
592 | (2) |
|
Absence of the gallbladder |
|
|
592 | (1) |
|
|
|
592 | (1) |
|
|
|
593 | (1) |
|
|
|
594 | (1) |
|
Rokitansky-Aschoff sinuses |
|
|
594 | (1) |
|
|
|
594 | (1) |
|
Diverticula of the gallbladder and ducts |
|
|
594 | (1) |
|
Intra-hepatic gallbladder |
|
|
594 | (1) |
|
Congenital adhesions to the gallbladder |
|
|
594 | (1) |
|
Floating gallbladder and torsion of the gallbladder |
|
|
594 | (1) |
|
Anomalies of the cystic duct and cystic artery |
|
|
595 | (2) |
|
Gallstones and Inflammatory Gallbladder Diseases |
|
|
597 | (32) |
|
Composition of gallstones |
|
|
597 | (1) |
|
|
|
597 | (1) |
|
Factors in cholesterol gallstone formation |
|
|
598 | (5) |
|
|
|
603 | (1) |
|
|
|
603 | (1) |
|
Natural history of gallstones |
|
|
604 | (1) |
|
|
|
605 | (1) |
|
Treatment of gallstones in the gallbladder |
|
|
605 | (2) |
|
|
|
605 | (1) |
|
Laparoscopic cholecystectomy |
|
|
605 | (2) |
|
Non-surgical treatment of gallstones in the gallbladder |
|
|
607 | (2) |
|
|
|
607 | (1) |
|
Direct solvent dissolution |
|
|
608 | (1) |
|
|
|
608 | (1) |
|
Percutaneous cholecystolithotomy |
|
|
609 | (1) |
|
|
|
609 | (1) |
|
|
|
610 | (2) |
|
Empyema of the gallbladder |
|
|
612 | (1) |
|
Perforationof the gallbladder |
|
|
612 | (1) |
|
Emphysematous cholecystitis |
|
|
612 | (1) |
|
Chronic calculous cholecystitis |
|
|
613 | (1) |
|
|
|
614 | (1) |
|
|
|
614 | (1) |
|
|
|
614 | (1) |
|
|
|
614 | (1) |
|
Acute cholecystitis in AIDS |
|
|
614 | (1) |
|
|
|
615 | (1) |
|
Other gallbladder pathology |
|
|
615 | (1) |
|
Cholesterolosis of the gallbladder |
|
|
615 | (1) |
|
Xanthogranulomatous cholecystitis |
|
|
615 | (1) |
|
|
|
615 | (1) |
|
|
|
615 | (1) |
|
Post-cholecystectomy problems |
|
|
615 | (1) |
|
Sphincter of Oddi dysfunction |
|
|
616 | (1) |
|
Gallstones in the common bile duct (choledocholithiasis) |
|
|
616 | (2) |
|
Management of common duct stones |
|
|
618 | (1) |
|
Acute obstructive suppurative cholangitis |
|
|
618 | (1) |
|
|
|
618 | (1) |
|
Common duct stones without cholangitis |
|
|
619 | (2) |
|
Patients with gallbladder in situ |
|
|
619 | (1) |
|
Acute gallstone pancreatitis |
|
|
619 | (1) |
|
|
|
619 | (1) |
|
Trans T-tube tract removal of stones |
|
|
620 | (1) |
|
|
|
620 | (1) |
|
|
|
620 | (1) |
|
|
|
621 | (1) |
|
|
|
621 | (1) |
|
|
|
621 | (1) |
|
|
|
621 | (1) |
|
|
|
622 | (1) |
|
|
|
622 | (1) |
|
Association of gallstones with other diseases |
|
|
623 | (6) |
|
Colorectal and other cancers |
|
|
623 | (1) |
|
|
|
623 | (6) |
|
Benign Stricture of the Bile Ducts |
|
|
629 | (10) |
|
|
|
629 | (5) |
|
Bile duct/bowel anastomotic stricture |
|
|
634 | (1) |
|
Post liver transplantation |
|
|
635 | (1) |
|
Primary sclerosing cholangitis |
|
|
636 | (1) |
|
|
|
636 | (1) |
|
|
|
636 | (3) |
|
Diseases of the Ampulla of Vater and Pancreas |
|
|
639 | (8) |
|
|
|
639 | (5) |
|
Benign villous adenoma of the ampulla of Vater |
|
|
644 | (1) |
|
Cystic tumours of the pancreas |
|
|
644 | (1) |
|
Endocrine tumours of the pancreas |
|
|
644 | (1) |
|
|
|
644 | (1) |
|
Obstruction of the common bile duct by enlarged lymph glands |
|
|
645 | (2) |
|
Other causes of extrinsic pressure on the common bile duct |
|
|
645 | (2) |
|
Tumours of the Gallbladder and Bile Ducts |
|
|
647 | (10) |
|
Benign lesions of the gallbladder |
|
|
647 | (1) |
|
Carcinoma of the gallbladder |
|
|
647 | (1) |
|
|
|
648 | (1) |
|
Benign tumours of the extra-hepatic bile duct |
|
|
648 | (1) |
|
Carcinoma of the bile duct (cholangiocarcinoma) |
|
|
648 | (6) |
|
Cholangiocellular carcinoma |
|
|
654 | (1) |
|
|
|
655 | (2) |
|
|
|
657 | (24) |
|
|
|
657 | (1) |
|
|
|
657 | (6) |
|
|
|
659 | (1) |
|
Autoimmune chronic hepatitis |
|
|
659 | (1) |
|
|
|
659 | (1) |
|
|
|
660 | (1) |
|
|
|
660 | (1) |
|
Cholestatic liver disease |
|
|
660 | (1) |
|
Primary metabolic disease |
|
|
661 | (1) |
|
|
|
662 | (1) |
|
|
|
662 | (1) |
|
|
|
663 | (1) |
|
Absolute and relative contraindications |
|
|
663 | (1) |
|
|
|
663 | (1) |
|
|
|
664 | (1) |
|
General preparation of the patient |
|
|
664 | (1) |
|
Donor selection and operation |
|
|
664 | (1) |
|
|
|
665 | (2) |
|
Segmental (split liver) transplantation |
|
|
665 | (1) |
|
Auxiliary liver transplantation |
|
|
666 | (1) |
|
|
|
666 | (1) |
|
Domino liver transplantation |
|
|
666 | (1) |
|
Hepatocyte transplantation |
|
|
667 | (1) |
|
Liver transplantation in paediatrics |
|
|
667 | (1) |
|
|
|
667 | (1) |
|
|
|
668 | (1) |
|
|
|
668 | (1) |
|
Post-transplantation complications |
|
|
668 | (7) |
|
|
|
671 | (2) |
|
|
|
673 | (2) |
|
|
|
675 | (1) |
|
|
|
675 | (1) |
|
|
|
675 | (1) |
|
Central nervous system toxicity |
|
|
675 | (1) |
|
|
|
675 | (1) |
|
Ectopic soft-tissue calcification |
|
|
675 | (1) |
|
|
|
675 | (6) |
| Index |
|
681 | |
Other versions by this Author
eCampus.com Device Compatibility Matrix
Apple iOS | iPad, iPhone, iPod
Android Devices | Android Tables & Phones OS 2.2 or higher | *Kindle Fire
Windows 10 / 8 / 7 / Vista / XP
Mac OS X | **iMac / MacbookEnjoy offline reading with these devices
Android 2.2 +
